[Adherence to endocrine therapy: A major issue in breast cancer management]. / L'adhésion à l'hormonothérapie adjuvante : un enjeu majeur dans la prise en charge du cancer du sein.
Bull Cancer
; 2024 Jun 18.
Article
em Fr
| MEDLINE
| ID: mdl-38897911
ABSTRACT
Endocrine therapy plays a crucial role in the treatment of women with hormone receptor-positive breast cancer. However, non-adherence remains a frequent issue known to negatively impact survival. Based on a comprehensive literature review, this article explores the terminologies employed to describe adherence and methods used for its assessment, the adherence data reported with adjuvant endocrine therapy with targeted therapies, the determinants of adherence or non-adherence, and finally, tested solutions to address it. The results show that a better understanding of the causes of non-adherence would help to better identify patients at risk, and to develop personalized intervention programs capable of improving adherence to adjuvant endocrine therapy. In light of the literature, interventions are likely to require a multimodal approach and integration into our future healthcare pathways.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
Fr
Revista:
Bull Cancer
Ano de publicação:
2024
Tipo de documento:
Article